Posted inBusiness Insights
AstraZeneca COPD Drug Scores Major Trial Wins Boosting Sales Hopes
AstraZeneca's experimental COPD drug achieves success in two late-stage clinical trials, strengthening projections for over $5 billion in peak sales.
